Proteomic analysis of exosome-like vesicles derived from breast cancer cells

Anticancer Research

Volumn 32, Issue 3, 2012, Pages 847-860

  Palazzolo, Gemma ^a   Albanese, Nadia Ninfa ^b,c   Di Cara, Gianluca ^c   Gygax, Daniel ^d   Vittorelli, Maria Letizia ^c   Pucci Minafra, Ida ^c  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF PALERMO   (Italy)

^c LA MADDALENA CANCER CENTER   (Italy)

^d UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

Author keywords

2D PAGE; Breast cancer; Extracellular vesicles; MALDI ToF; Mass spectrometry; MDA MB 231 cells; Protein biomarker; Proteomic profiling

Indexed keywords

BIOLOGICAL MARKER; HEAT SHOCK PROTEIN 70; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PROTEOME;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRUCTURE; CELL ULTRASTRUCTURE; EXOSOME; EXOSOME LIKE VESICLE; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; STROMA CELL; TRANSMISSION ELECTRON MICROSCOPY; ULTRACENTRIFUGATION; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; CULTURE MEDIA, SERUM-FREE; EXOSOMES; FEMALE; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASM PROTEINS; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84858776611     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Black PH: Shedding from normal and cancer-cell surfaces. N Engl J Med 303: 1415-1416, 1980.
2. György B, Szabó TG, Pásztói M, Pál Z, Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A, Nagy G, Falus A and Buzás EI: Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68: 2667-2688, 2011.
3. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W and Geuze HJ: Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 19: 3365-3374, 2000.
4. van Niel G, Porto-Carreiro I, Simoes S and Raposo G: Exosomes: a common pathway for a specialized function. J Biochem 140: 13-21, 2006. (Pubitemid 44433541)
5. Chargaff E and West R: The biological significance of the thromboplastic protein of blood. J Biol Chem 166: 189-197, 1946.
6. Leroyer AS, Tedgui A and Boulanger CM: Role of microparticles in atherothrombosis. J Intern Med 263: 528-537, 2008. (Pubitemid 351533557)
7. Boilard E, Nigrovic PA, Larabee K, Watts, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O'Donnell E, Farndale RW, Ware J and Lee DM: Platelets amplify inflammation in arthritis via collagendependent microparticle production. Science 327: 580-583, 2010.
8. Vittorelli ML: Shed membrane vesicles and clustering of membranebound proteolytic enzymes. Curr Top Dev Biol 54: 411-432, 2003.
9. Giusti I, D'Ascenzo S, Millimaggi D, Taraboletti, Carta G, Franceschini N, Pavan A and Dolo V: Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. Neoplasia 10: 481-488, 2008. (Pubitemid 351657390)
10. Antonyak MA, Li B, Boroughs LK, Johnson JL, Druso JE, Bryant KL, Holowka DA and Cerione RA: Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci USA 108: 4852-4857, 2011.
11. Taverna S, Ghersi G, Ginestra A, Rigogliuso S, Pecorella S, Alaimo G, Saladino F, Dolo V, Dell'Era P, Pavan A, Pizzolanti G, Mignatti P, Presta M and Vittorelli ML: Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. J Biol Chem 278: 51911-51919, 2003. (Pubitemid 38020438)
12. Taverna S, Rigogliuso S, Salamone M, Vittorelli ML: Intracellular trafficking of endogenous fibroblast growth factor-2. FEBS J 275: 1579-1592, 2008. (Pubitemid 351388803)
13. Rigogliuso S, Donati C, Cassarà D, Taverna S, Salamone M, Bruni P and Vittorelli ML: An active form of sphingosine kinase-1 is released in the extracellular medium as component of membrane vesicles shed by two human tumor cell lines. J Oncol 509329, 2010.
14. Pap E, Pállinger E, Falus A, Kiss AA, Kittel A, Kovács P and Buzás EI: T-Lymphocytes are targets for platelet- and trophoblast-derived microvesicles during pregnancy. Placenta 29: 826-832, 2009.
15. Kerr JF, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26(4): 239-57, 1972.
16. Beyer C and Pisetsky DS: The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol 6: 21-29, 2010.
17. Mears R, Craven RA, Hanrahan S, Totty N, Upton C, Young SL, Patel P, Selby PJ and Banks RE: Proteomic analysis of melanoma derived exosomes by two dimensional Polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 4: 4019-4031, 2004. (Pubitemid 39657475)
18. Dolo V, Adobati E, Canevari S, Picone MA and Vittorelli ML: Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens. Clin Exp Metastasis 13: 277-286, 1995.
19. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E and Zitvogel L: Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360: 295-305, 2002. (Pubitemid 34874721)
20. Dolo V, Ginestra A, Cassarà D, Violini S, Lucania G, Torrisi MR, Nagase H, Canevari S, Pavan A and Vittorelli ML: Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res 58: 4468-4474, 1998. (Pubitemid 28450053)
21. Ginestra A, La Placa MD, Saladino F, Cassarà D, Nagase H and Vittorelli ML: The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res 18: 3433-3437, 1998. (Pubitemid 28546471)
22. Dolo V, D'Ascenzo S, Violini S, Pompucci L, Festuccia C, Ginestra A, Vittorelli ML, Canevari S and Pavan A: Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis 17: 131-140, 1999. (Pubitemid 29335439)
23. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
24. Simpson RJ, Jensen SS and Lim JW: Proteomic profiling of exosomes: Current perspectives. Proteomics 8: 4083-4099, 2008.
25. Pucci-Minafra I, Fontana S, Cancemi P, Alaimo G and Minafra S: Proteomic patterns of cultured breast cancer cells and epithelial mammary cells. Ann NY Acad Sci 963: 122-139, 2002. (Pubitemid 34721704)
26. Pucci-Minafra I, Fontana S, Cancemi P, Basiricò L, Caricato S and Minafra S: A contribution to breast cancer cell proteomics: detection of new sequences. Proteomics 2: 919-927, 2002. (Pubitemid 34803975)
27. Pucci-Minafra I, Cancemi P, Albanese NN, Di Cara G, Marabeti MR, Marrazzo A and Minafra S: New protein clustering of breast cancer tissue proteomics using actin content as a cellularity indicator. J Proteome Res 7: 1412-1418, 2008.
28. Gatlin CL, Eng JK, Cross ST, Detter JC and Yates III JR: Automated identification of amino acid sequence variations in proteins by HPLC/microspray tandem mass spectrometry. Anal Chem 72: 757-763, 2000. (Pubitemid 30111516)
29. Keller S, Sanderson MP, Stoeck A and Altevogt P: Exosomes: From biogenesis and secretion to biological function. Immunol Lett 107: 102-108, 2006. (Pubitemid 44779821)
30. Mei Y, Yong J, Stonestrom A and Yang X: tRNA and cytochrome c in cell death and beyond. Cell Cycle 9: 2936-2939, 2010.
31. Eskelinen EL, Tanaka Y and Saftig P: At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol 13: 137-145, 2003. (Pubitemid 36293786)
32. Garrigues J, Anderson J, Hellstrom KE and Hellstrom I: Anti tumor antibody BR96 blocks cell migration and binds to a lysosomal membrane glycoprotein on cell surface microspikes and ruffled membranes. J Cell Biol 125: 129-142, 1994. (Pubitemid 24100044)
33. Becker J and Craig EA: Heat-shock proteins as molecular chaperones. Eur J Biochem 219: 11-23, 1994. (Pubitemid 24053613)
34. Thery C, Zitvogel L and Amigorena S: Exosomes: composition, biogenesis and function. Nat Rev Immunol 2: 569-579, 2002. (Pubitemid 37328732)
35. Thiery JP and Chopin D: Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev 18(1): 31-42, 1999. (Pubitemid 29411090)
36. Fulda S: Cell death and survival signaling in oncogenesis. Klin Padiatr 222(6): 340-344, 2010.
37. Vander Heiden MG: Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov 10(9): 671-684, 2011.
38. Fevrier B and Raposo G: Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Op Cell Biol 16: 415-421, 2004. (Pubitemid 38903148)
39. Kawakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Kagara I, Gotanda T, Tachiwada T, Nishiyama K, Nohata N, Seki N and Nakagawa M: The functional significance of miR-1 and miR-133a in renal cell carcinoma. Eur J Cancer Jul 9, 2011. [Epub ahead of print].
40. Chatellard-Causse C, Blot B, Cristina N, Torch, Missotten M and Sadoul R: Alix (ALG-2-interacting protein X), a protein involved in apoptosis, binds to endophilins and induces cytoplasmic vacuolization. J Biol Chem 277: 29108-29115, 2002.
41. D'Agostino S, Salamone M, Di Liegro I and Vittorelli ML: Membrane vesicles shed by oligodendroglioma cells induce neuronal apoptosis. Int J Oncol 29: 1075-1085, 2006.
42. Admyre C, Johansson SM, Qazi KR, Filén JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A and Gabrielsson S: Exosomes with immune modulatory features are present in human breast milk. J Immunol 179: 1969-1978, 2007.
43. Staubach S, Razawi H and Hanisch FG: Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7. Proteomics 9: 2820-2835, 2009.
44. Mathivanan S and Simpson RJ: ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 9: 4997-5000, 2009.
45. Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, Lim SK and Sze SK: Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics 9: 1085-1099, 2010.
46. Liang S, Xu Y, Shen G, Liu Q, Zhao X, Xu Z, Xie X, Gong F, Li R and Wei Y: Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation. Electrophoresis 30: 4152-4162, 2009.
47. Ko BS, Chang TC, Hsu C, Chen YC, Shen TL, Chen SC, Wang J, Wu KK, Jan YJ and Liou JY: Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma. Histopathology 58: 705-711, 2011.
48. Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, Wang NS and Knepper MA: Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 20: 363-379, 2009.
49. Morita E, Colf LA, Karren MA, Sandrin V, Rodesch CK and Sundquist WI: Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance. Proc Natl Acad Sci USA 107: 12889-12894, 2010.
50. Albiges-Rizo C, Destaing O, Fourcade B, Planus E and Block MR: Actin machinery and mechanosensitivity in invadopodia, podosomes and focal adhesions. J Cell Sci 122: 3037-3049, 2009.
51. Desmetz C, Bascoul-Mollevi C, Rochaix P, Lamy PJ, Kramar A, Rouanet P, Maudelonde T, Mangé A and Solassol J: Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women. Clin Cancer Res 15: 4733-4741, 2009.
52. Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ and Shao ZM: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer Breast Cancer Res 9: R76, 2007.
53. Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim YK, Kwon KH, Kwon HJ, Kim KP and Gho YS: Proteomic analysis of microvesicles derived from human colorectal cancer cells. J Proteome Res 6: 4646-4655, 2007.
54. Pucci-Minafra I, Minafra S, Faccini AM and Alessandro R: An ultrastructural evaluation of cell heterogeneity in invasive ductal carcinomas of the human breast I. An in vivo study. J Submicrosc Cytol Pathol 21: 475-488, 1989. (Pubitemid 19185028)
55. Pucci-Minafra I, Minafra S, Alessandro R and Faccini AM: An ultrastructural evaluation of cell heterogeneity in invasive ductal carcinomas of the human breast II. An in vitro study. J Submicrosc Cytol Pathol 21: 489-99, 1989. (Pubitemid 19185029)
56. Ginestra A, Miceli D, Dolo V, Romano FM and Vittorelli ML: Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Res 19: 3439-3445, 1999. (Pubitemid 30000200)
57. Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS and Fishman DA: Proinvasive properties of ovarian cancer ascitesderived membrane vesicles. Cancer Res 64: 7045-7049, 2004. (Pubitemid 39331015)
58. Castellana D, Kunzelmann C and Freyssinet JM: Pathophysiologic significance of procoagulant microvesicles in cancer disease and progression. Hämostaseologie 29: 51-57, 2009.
59. Muralidharan-Chari V, Clancy JW, Sedgwick A and D'Souza-Schorey C: Microvesicles: mediators of extracellular communication during cancer progression. J Cell Science 123: 1603-1611, 2010.
60. Subramani D and Alahari SK: Integrin-mediated function of Rab GTPases in cancer progression. Molecular Cancer 9: 312, 2010.